The obsession with being fit and thin in the workplace is on the rise, fueled in part by the increasing use of weight loss drugs making headlines. This craze has also sparked a resurgence of “fatphobia”, which often leads to unequal opportunities for employees facing obesity. Employers traditionally cover widely accepted diseases under their healthcare plans, but when it comes to weight loss, obesity as a disease is heavily debated. Can employers be held liable for discrimination if they don’t offer weight loss drugs as a benefit? This session will shed light on discrimination through the lens of an employer’s benefits portfolio, the surging popularity of weight loss drugs, dispelling myths, and presenting facts, as well as how employers can support their obese workforce with an equitable plan focusing on inclusivity, employee well-being, and a culture of respect in mind.